Methamphetamine-associated severe coronary artery ectasia presenting as ST-elevation myocardial infarction in young adult

  • Chanokporn Puchongmart Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA
  • Natnicha Jakramonpreeya Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samut Prakan, Thailand
  • Weerinth Puyati Central Chest Institute of Thailand, Nonthaburi, Thailand
  • Ben Thiravetyan Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA

Abstract

While cocaine has been reported as a risk factor for coronary artery ectasia (CAE), the effects of other stimulants, such as methamphetamine, on CAE is inadequately described. We present a case of a mid-40s man with a history of hypertension, hyperlipidemia, and methamphetamine abuse who presented with acute-onset chest pain. His electrocardiogram indicated an inferior wall ST-elevation myocardial infarction (STEMI). Coronary angiography revealed diffuse and severe CAE with complete thrombotic occlusion of distal RCA and large thrombus burden in mid-RCA segment. Percutaneous coronary intervention was performed in the distal RCA. However, residual thrombus persisted in the mid-RCA segment. He was later discharged on dual antiplatelet therapy with a plan to initiate anticoagulation in the outpatient setting due to right groin hematoma. Prior studies regarding CAE and methamphetamine are still limited. In addition to his atherosclerotic risk factors, methamphetamine may have also contributed to the development of CAE.

Keywords: Coronary artery ectasia; Methamphetamine; Myocardial infarction

Downloads

Download data is not yet available.

References

1. Eid MM, Mostafa MR, Alabdouh A, et al. Long-term Outcomes of Acute Myocardial Infarction in Pre-existing Coronary Artery Ectasia: A Systematic Review and Meta-Analysis. Curr Probl Cardiol 2023;48(5):101626. DOI: 10.1016/j.cpcardiol.2023.101626.
2. Li Y, Wu C, Liu W. Coronary artery ectasia presenting with thrombus embolization and acute myocardial infarction: A case report. Medicine (Baltimore) 2017;96(4):e5976. DOI: 10.1097/MD.0000000000005976.
3. Satran A, Bart BA, Henry CR, et al. Increased prevalence of coronary artery aneurysms among cocaine users. Circulation 2005;111(19):2424-9. DOI: 10.1161/01.CIR.0000165121.50527.DE.
4. Barros G, Porto D, Rua Z, Renowitzky C, Urina-Triana MA. MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION IN A YOUNG WOMAN WITH CORONARY ARTERY ECTASIA AND ANEURYSM: A CASE REPORT. JACC 2024;83(13_Supplement):4363-4363. DOI: doi:10.1016/S0735-1097(24)06353-8.
5. Amin AS, Hoseyni Guyomi S, Buijs EM, De Milliano PA. Coronary ectasia and repeated myocardial infarction in a young man. Int J Cardiol 2014;171(3):e74-5. DOI: 10.1016/j.ijcard.2013.11.102.
6. Devabhaktuni S, Mercedes A, Diep J, Ahsan C. Coronary Artery Ectasia-A Review of Current Literature. Curr Cardiol Rev 2016;12(4):318-323. DOI: 10.2174/1573403x12666160504100159.
7. Aboeata AS, Sontineni SP, Alla VM, Esterbrooks DJ. Coronary artery ectasia: current concepts and interventions. Front Biosci (Elite Ed) 2012;4(1):300-10. DOI: 10.2741/377.
8. Dendramis G, Paleologo C, Piraino D, Assennato P. Relationship between coronary artery ectasia, cocaine abuse and acute coronary syndromes. World J Cardiol 2016;8(5):351-5. DOI: 10.4330/wjc.v8.i5.351.
9. Kevil CG, Goeders NE, Woolard MD, et al. Methamphetamine Use and Cardiovascular Disease. Arterioscler Thromb Vasc Biol 2019;39(9):1739-1746. DOI: 10.1161/ATVBAHA.119.312461.
10. Martins T, Baptista S, Goncalves J, et al. Methamphetamine transiently increases the blood-brain barrier permeability in the hippocampus: role of tight junction proteins and matrix metalloproteinase-9. Brain Res 2011;1411:28-40. DOI: 10.1016/j.brainres.2011.07.013.
11. Li T, Li X, Feng Y, Dong G, Wang Y, Yang J. The Role of Matrix Metalloproteinase-9 in Atherosclerotic Plaque Instability. Mediators Inflamm 2020;2020:3872367. DOI: 10.1155/2020/3872367.
12. Ahmad M, Mungee S. Coronary Ectasia. StatPearls Publishing. (https://www.ncbi.nlm.nih.gov/books/NBK541130/).
13. Antoniadis AP, Chatzizisis YS, Giannoglou GD. Pathogenetic mechanisms of coronary ectasia. Int J Cardiol 2008;130(3):335-43. DOI: 10.1016/j.ijcard.2008.05.071.
14. Esposito L, Di Maio M, Silverio A, et al. Treatment and Outcome of Patients With Coronary Artery Ectasia: Current Evidence and Novel Opportunities for an Old Dilemma. Front Cardiovasc Med 2021;8:805727. DOI: 10.3389/fcvm.2021.805727.
15. Azarboo A, Daneshvar MS, Abroy AS, et al. Antithrombotic therapy in adults with ectatic coronary artery disease: a systematic review and network meta-analysis. Egypt Heart J 2025;77(1):13. DOI: 10.1186/s43044-025-00612-8.
16. Araiza-Garaygordobil D, Gopar-Nieto R, Sierra-Lara Martinez JD, et al. A randomized trial of antithrombotic therapy in patients with acute coronary syndrome and coronary ectasia. Am Heart J 2025;281:103-111. DOI: 10.1016/j.ahj.2024.11.012.
17. Pranata R, Yonas E, Chintya V, Alkatiri AA. Is Anticoagulant Necessary in Patients with Coronary Artery Ectasia Presenting with Acute Coronary Syndrome? A Systematic Review of Case Reports. Int J Angiol 2019;28(4):231-236. DOI: 10.1055/s-0039-1692706.
Published
2026-03-06